Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBIT Margin (2016 - 2018)

Historic EBIT Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 829.08%.

  • Armata Pharmaceuticals' EBIT Margin rose 126540800.0% to 829.08% in Q4 2018 from the same period last year, while for Dec 2018 it was 1127.68%, marking a year-over-year increase of 151763700.0%. This contributed to the annual value of 762.14% for FY2024, which is 29108500.0% up from last year.
  • As of Q4 2018, Armata Pharmaceuticals' EBIT Margin stood at 829.08%, which was up 126540800.0% from 791.21% recorded in Q3 2018.
  • Armata Pharmaceuticals' EBIT Margin's 5-year high stood at 1011.74% during Q2 2018, with a 5-year trough of 53927.27% in Q4 2016.
  • Its 5-year average for EBIT Margin is 8068.94%, with a median of 2571.29% in 2014.
  • As far as peak fluctuations go, Armata Pharmaceuticals' EBIT Margin surged by 729546900bps in 2014, and later crashed by -516304000bps in 2016.
  • Armata Pharmaceuticals' EBIT Margin (Quarter) stood at 2571.29% in 2014, then grew by 11bps to 2296.88% in 2015, then tumbled by -2248bps to 53927.27% in 2016, then skyrocketed by 78bps to 11825.0% in 2017, then surged by 107bps to 829.08% in 2018.
  • Its EBIT Margin stands at 829.08% for Q4 2018, versus 791.21% for Q3 2018 and 1011.74% for Q2 2018.